Product Images Carbidopa, Levodopa And Entacapone

This text is a description of Carbidopa, Levodopa and Entacapone Tablets. It includes information such as the active ingredients, dosage instructions, storage guidelines, and a warning against overdose. It also includes manufacturing and distribution details, and a caution about combining the tablets to obtain a higher strength.*

This is a product description for Carbidopa, Levodopa, and Entacapone Tablets. The tablets come in a film-coated form, and each tablet contains certain ingredients in specific quantities. The tablets should be stored at a temperature of 25 °C. The text also contains a caution against combining tablets to achieve higher strength. The text seems to be cut off, and there is no clear use case or explanation beyond these details.*

This is a description for Carbidopa, Levodopa And Entacapone Tablets with Lot number 144461-2 and NOC 61679-787-04. These tablets are film-coated and each tablet contains Carbidopa USP and Entacapone. The tablets should not be combined with other high or strong tablet duos and should not be overdosed. The dosage should be taken as per package insert and the tablet should be swallowed without crushing, splitting or chewing. The tablets should be stored at a temperature of 25°C with permitted excursions up to 15-30°C. It should be dispensed in a tight container and kept out of reach of children. The manufacturer of the tablets is Orion Corporation in Finland and it is distributed by Wocknar UGALLC in Parsippany, New Jersey, USA.*

This is a description of a medication named "Carbidopa, Levodopa and Entacapone Tablets" which comes in a film-coated form. The warning on the packaging advises against combining tablets to avoid overdosing of entacapone. The medicine should not be chewed, crushed, or split but swallowed directly. It should be stored in a dry place at room temperature. The drug is dispensed in a tight container and kept out of the children's reach. The manufacturer is Orion Pharma and distributed by Wocknar USA LLC.*

This is a medication label for a tablet containing carbidopa, levodopa, and entacapone. It is advised not to combine tablets to achieve a higher strength due to the risk of entacapone overdose. The recommended dosage is detailed in the package insert, and the tablets must be swallowed whole without crushing or chewing. Storage should be done at temperatures between 15°C to 30°C. This medication is produced by Fovand and distributed by Wiocar USALLE in the USA.*

This text appears to be from a medication package for Carbidopa, Levodopa and Entacapone Tablets. The medication should be stored at room temperature (25°C or 77°F) and should not be crushed or spit. The packet also includes information about the manufacturer and distribution, as well as a warning not to combine tablets to achieve a higher dose due to the risk of Entacapone overdose.*